Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Egyesült ÁllamokFázis nélkül

Developing a Smartphone Application to Support Veteran Opioid Use Disorder Treatment

A legfontosabb adatok

Ki végzi
VA Office of Research and Development
Hol
West Haven (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Toboroz
Résztvevők
75 fő, tervezett
Kezdés
2025. ápr. 2.
Várható befejezés
2029. okt. 31.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport színlelt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • ACT to RECOVER
  • Smartphone-based Symptom-Monitoring
A regiszteradat frissítve
2026. augusztus 17.

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 9 feltétel megnézéseKevesebb

Ki vehet részt

  • -For the Phase 3, Stage 1b RCT The investigators will be recruiting Veterans engaged in MOUD who also demonstrate deficits in psychosocial functioning (N = 40, n = 20 per condition)
  • Eligible Veterans in must have:
  • a current Opioid Use Disorder (OUD) diagnosis
  • active Medication treatment for OUD (MOUD) prescription for buprenorphine or methadone
  • have a Veterans Rand 12 (VR-12) Physical Component Scale (PCS) or Mental Component Scale (MCS) that is <1SD below the normed mean for their respective sex-assigned-at-birth (Selim et al., 2008)

Ki nem vehet részt

  • have untreated major psychiatric disorders (e.g., psychotic disorders)
  • Participants may not:
  • current (i.e., past-month) suicidal/homicidal ideation with intent (i.e., a positive C-SSRS)
  • cognitive/medical impairments precluding meaningful participation (via clinician determination based on participant's behavior and/or chart review)

Ez a vizsgálat jelenleg itt érhető el: Egyesült Államok.

  • VA Connecticut Healthcare System West Haven Campus, West Haven, CTWest Haven, Egyesült ÁllamokContact: Noah R Wolkowicz, PhDRésztvevőt keres

A vizsgálatról

Mit akar kideríteni a vizsgálat

Opioid Use Disorder (OUD) is a complex, chronic condition affecting nearly 70,000 Veterans who can experience significantly reduced quality of life (e.g., poorer social, occupational, and health-related functioning). VA clinics providing Medication treatment for OUD (MOUD); e.g., buprenorphine, methadone), the 1st-line treatment for OUD, often face challenges in also attempting to treat Veteran functional needs, which may require them to extend beyond their available resources to provide support. There is an urgent need for functionally impactful and accessible treatments for Veterans in MOUD.

A teljes eredeti leírásKevesebb

Acceptance and Commitment Therapy (ACT) is a well-suited framework to support the functioning of Veterans in MOUD with over 20 years of research support. However, the traditional practice ACT requires a trained clinician to provide weekly, hour-long therapy sessions (typically for 12-16 weeks) and may be too burdensome for MOUD clinics to use alongside standard care.

Fortunately, emerging research suggests that mobile health interventions (MHIs; e.g., smartphone apps) can overcome many of these pragmatic barriers. MHIs can efficiently deliver functionally-focused treatments focused on Veteran functioning in "real-world" settings, through minimally burdensome and accessible formats. Currently however, no MHI's targeting functioning exist for Veterans in MOUD.

The proposed study will address this gap by developing and evaluating an early prototype of a targeted smartphone app designed to enhance the functional outcomes of Veterans receiving MOUD called "ACT to RECOVER" (Acceptance and Commitment Therapy to Reach Empowerment through Commitment, Openness, and Valuing Experiences in Recovery).

The study will occur in 3 phases:

Phase 1: Development. Develop content for ACT to RECOVER using Veteran (n=10) and provider feedback (n=10).

Phase 2: Iterative Usability Assessment. Conduct field testing (3 rounds, n=4-5 per round) to refine ACT to RECOVER format, acceptability, and usability.

Phase 3: Pilot ACT to RECOVER in a Stage 1b Randomized Controlled Trial (RCT). Conduct a pilot trial to compare ACT to RECOVER (n=20) to a smartphone-based symptom monitoring control group (n=20).

* (3a) Evaluate the acceptability and feasibility of each condition's app and study procedures. * (3b) Explore changes in functional (e.g., values-based living, quality of life) and clinical outcomes (e.g., illicit opioid use) which will be key outcomes in future efficacy testing.

A vizsgálat 2 csoportja

  • TreatmentA vizsgált kezelés

    This Phase 3 (Stage 1b RCT) Arm will consist of n = 20 Veterans (anticipated enrollment) who will receive the prototype ACT to RECOVER smartphone intervention for 4 weeks.

    Kezelés: ACT to RECOVER

  • ControlSzínlelt kezelés, összehasonlításként

    This Phase 3 (Stage 1b RCT) Arm will consist of n = 20 Veterans (anticipated enrollment) who will be assigned to receive a smartphone-based symptom-monitoring program for 4 weeks.

    Kezelés: Smartphone-based Symptom-Monitoring

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Developing a Smartphone Application to Support the Functional Needs of Veterans in Medication Treatment for Opioid Use Disorder
A regiszteradat frissítve
2026. augusztus 17.